NCT00448760 Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00448682 Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00447967 Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients Status COMPLETED Phase PHASE2
NCT00422864 A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer Status COMPLETED Phase PHASE2
NCT00418938 SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial Status COMPLETED Phase PHASE2
NCT00354978 Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT00337389 Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Status UNKNOWN Phase PHASE3
NCT00335140 Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Status TERMINATED Phase PHASE2
NCT00323583 Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT00321828 Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00309543 Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B Status COMPLETED Phase PHASE3
NCT00309517 Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C Status TERMINATED Phase PHASE3
NCT00308516 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer Status COMPLETED Phase PHASE2
NCT00305188 Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. Status COMPLETED Phase PHASE3
NCT00278889 Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) Status COMPLETED Phase PHASE2
NCT00267865 Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma Status COMPLETED Phase PHASE2
NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00235898 Clinical Trial in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00233623 Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00227617 Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors Status TERMINATED Phase PHASE2/PHASE3